Atlassian Forecast, price target & analysts
Atlassian Target price 2025 - Analyst rating & recommendation
Atlassian Classifications & Recommendation:
Atlassian Price Target
| Target Price | $279.00 |
| Price | $214.51 |
| Potential | 30.06% |
| Number of Estimates | 26 |
| 26 Analysts have issued a price target Atlassian 2026 . The average Atlassian target price is $279.00. This is 30.06% higher than the current stock price. The highest price target is $420.00 95.80% , the lowest is $215.00 0.23% . | |
| A rating was issued by 33 analysts: 24 Analysts recommend Atlassian to buy, 9 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Atlassian stock has an average upside potential 2026 of 30.06% . Most analysts recommend the Atlassian stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2029
27 Analysts have issued a sales forecast Atlassian 2025 . The average Atlassian sales estimate is $5.2b . This is 4.57% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $5.2b 5.33% , the lowest is $5.2b 4.42% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $4.4b | 23.31% |
|---|---|---|
| 2025 | $5.2b | 19.06% |
| 2026 | $6.2b | 18.79% |
| 2027 | $7.3b | 18.95% |
| 2028 | $8.5b | 16.06% |
| 2029 | $9.9b | 16.52% |
5 Analysts have issued an Atlassian EBITDA forecast 2025. The average Atlassian EBITDA estimate is $1.3b . This is 951.80% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $1.3b 972.74% , the lowest is $1.3b 927.25% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $-104m | 56.18% |
|---|---|---|
| 2025 | $1.3b | 1,355.90% |
| 2026 | $1.6b | 22.55% |
| 2027 | $2.0b | 24.25% |
EBITDA Margin
| 2024 | -2.39% | 64.46% |
|---|---|---|
| 2025 | 25.25% | 1,154.97% |
| 2026 | 26.05% | 3.17% |
| 2027 | 27.21% | 4.45% |
8 Atlassian Analysts have issued a net profit forecast 2025. The average Atlassian net profit estimate is $-297m . This is 30.97% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $-239m 44.27% , the lowest is $-353m 17.94% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $-301m | 38.26% |
|---|---|---|
| 2025 | $-297m | 1.29% |
| 2026 | $-169m | 42.88% |
| 2027 | $-12.2m | 92.80% |
Net Margin
| 2024 | -6.89% | 49.93% |
|---|---|---|
| 2025 | -5.72% | 17.04% |
| 2026 | -2.75% | 51.92% |
| 2027 | -0.17% | 93.82% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
8 Analysts have issued a Atlassian forecast for earnings per share. The average Atlassian EPS is $-1.13 . This is 30.67% higher than earnings per share in the financial year 2024. The highest EPS forecast is $-0.91 44.17% , the lowest is $-1.34 17.79% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $-1.16 | 38.95% |
|---|---|---|
| 2025 | $-1.13 | 2.59% |
| 2026 | $-0.64 | 43.36% |
| 2027 | $-0.05 | 92.19% |
P/E ratio
| Current | -131.60 | 48.82% |
|---|---|---|
| 2025 | -190.30 | 44.60% |
| 2026 | -333.13 | 75.06% |
| 2027 | -4,627.45 | 1,289.08% |
Based on analysts' sales estimates for 2025, the Atlassian stock is valued at an EV/Sales of 10.50 and an P/S ratio of 10.88 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 10.98 | 15.22% |
|---|---|---|
| 2025 | 10.50 | 4.38% |
| 2026 | 8.84 | 15.82% |
| 2027 | 7.43 | 15.93% |
| 2028 | 6.40 | 13.84% |
| 2029 | 5.49 | 14.18% |
P/S ratio
| Current | 11.38 | 16.11% |
|---|---|---|
| 2025 | 10.88 | 4.37% |
| 2026 | 9.16 | 15.82% |
| 2027 | 7.70 | 15.93% |
| 2028 | 6.64 | 13.84% |
| 2029 | 5.69 | 14.18% |
Current Atlassian Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays |
Overweight
➜
Overweight
|
Unchanged | May 05 2025 |
| Raymond James |
Outperform
➜
Outperform
|
Unchanged | May 02 2025 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | May 02 2025 |
| Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | May 02 2025 |
| Canaccord Genuity |
Buy
➜
Buy
|
Unchanged | May 02 2025 |
| Macquarie |
Outperform
➜
Outperform
|
Unchanged | May 02 2025 |
| Stephens & Co. |
Equal-Weight
➜
Equal-Weight
|
Unchanged | May 02 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
May 05 2025 |
|
Unchanged
Raymond James:
Outperform
➜
Outperform
|
May 02 2025 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
May 02 2025 |
|
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
May 02 2025 |
|
Unchanged
Canaccord Genuity:
Buy
➜
Buy
|
May 02 2025 |
|
Unchanged
Macquarie:
Outperform
➜
Outperform
|
May 02 2025 |
|
Unchanged
Stephens & Co.:
Equal-Weight
➜
Equal-Weight
|
May 02 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
